Scarica l'app Stockscreener
0.4625
5.05%
-0.0246
Dopo l'orario di chiusura:
.46
-0.0025
-0.54%
Precedente Chiudi:
$0.4871
Aprire:
$0.4908
Volume 24 ore:
257.89K
Relative Volume:
0.88
Capitalizzazione di mercato:
$36.42M
Reddito:
$9.53M
Utile/perdita netta:
$-44.61M
Rapporto P/E:
-0.5082
EPS:
-0.91
Flusso di cassa netto:
$-38.32M
1 W Prestazione:
-12.46%
1M Prestazione:
-26.59%
6M Prestazione:
-23.17%
1 anno Prestazione:
-50.80%
Intervallo 1D:
$0.4583
$0.499
Intervallo di 1 settimana:
$0.4583
$0.5399
Portata 52W:
$0.4583
$1.75
Cue Biopharma Inc Stock (CUE) Company Profile
Nome
Cue Biopharma Inc
Settore
Industria
Telefono
617-949-2680
Indirizzo
40 GUEST STREET, BOSTON, MA
Confronta CUE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CUE
Cue Biopharma Inc
|
0.4625 | 38.35M | 9.53M | -44.61M | -38.32M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cue Biopharma Inc Stock (CUE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-03-13 | Iniziato | Jefferies | Buy |
| 2023-06-26 | Ripresa | Oppenheimer | Outperform |
| 2022-11-21 | Iniziato | Piper Sandler | Overweight |
| 2022-01-13 | Iniziato | H.C. Wainwright | Buy |
| 2022-01-03 | Iniziato | Craig Hallum | Buy |
| 2020-11-24 | Iniziato | Berenberg | Buy |
| 2020-04-09 | Iniziato | Stifel | Buy |
| 2020-01-28 | Iniziato | BTIG Research | Buy |
| 2020-01-22 | Iniziato | JMP Securities | Mkt Outperform |
Mostra tutto
Cue Biopharma Inc Borsa (CUE) Ultime notizie
Does Cue Biopharma Inc (CUE) offer a good opportunity for investors? - Setenews
Cue Biopharma (CUE) Price Target Increased by 25.00% to 5.10 - Nasdaq
Will Cue Biopharma Inc. stock continue upward momentum2025 Price Momentum & Fast Gain Stock Trading Tips - Newser
Is Cue Biopharma Inc. stock a safe investment in uncertain marketsDip Buying & Stepwise Trade Signal Implementation - Newser
How Cue Biopharma Inc. stock reacts to inflationary pressuresTrade Signal Summary & Real-Time Volume Triggers - Newser
Is Cue Biopharma Inc. (1UC) stock dividend growth reliableSwing Trade & Community Consensus Picks - Newser
Is Cue Biopharma Inc. (1UC) stock testing key supportStop Loss & Long-Term Safe Investment Ideas - Newser
What Wall Street predicts for Cue Biopharma Inc. stock price2025 Breakouts & Breakdowns & Safe Entry Zone Identification - Newser
Will Cue Biopharma Inc. (1UC) stock benefit from infrastructure billQuarterly Earnings Report & Long-Term Capital Growth Strategies - Newser
How Cue Biopharma Inc. (1UC) stock moves in volatile trading sessionsOil Prices & High Conviction Buy Zone Alerts - Newser
Can Cue Biopharma Inc. stock rebound after recent weakness2025 Volume Leaders & Technical Buy Zone Confirmation - BỘ NỘI VỤ
Is Cue Biopharma Inc (CUE) positioned for future growth? - Setenews
Will Cue Biopharma Inc. stock benefit from AI adoptionMarket Risk Summary & Community Supported Trade Ideas - moha.gov.vn
[Form 4] Cue Biopharma, Inc. Insider Trading Activity - Stock Titan
Cue Biopharma Releases Updated Corporate Presentation - TipRanks
[8-K] Cue Biopharma, Inc. Reports Material Event | CUE SEC FilingForm 8-K - Stock Titan
Cue Biopharma, Inc. (CUE) Reports Q3 Loss, Lags Revenue Estimates - MSN
Can Cue Biopharma Inc. stock resist market sell offsGlobal Markets & Smart Swing Trading Alerts - newser.com
Will Cue Biopharma Inc. stock recover faster than peers2025 Top Gainers & Risk Controlled Daily Trade Plans - newser.com
Is Cue Biopharma Inc. stock dividend yield sustainableWeekly Trade Report & Verified Chart Pattern Signals - newser.com
Cue Biopharma Announces CMO Departure - TipRanks
Cue Biopharma Announces Departure of Chief Medical Officer - TradingView
Cue Biopharma, Inc. Announces Termination of Matteo Levisetti as Chief Medical Officer, Effective November 28, 2025 - MarketScreener
Why Cue Biopharma Inc. (1UC) stock benefits from AI revolutionEarnings Beat & Reliable Trade Execution Plans - newser.com
Is Cue Biopharma Inc. stock trading at a premium valuationPortfolio Risk Report & Risk Adjusted Buy/Sell Alerts - newser.com
Will Cue Biopharma Inc. (1UC) stock deliver compounding returns2025 Market WrapUp & Risk Controlled Daily Plans - newser.com
Asia Deal Watch: GSK To Collaborate With LTZ On Myeloid Cell Engagers - Citeline News & Insights
Why Cue Biopharma Inc. (1UC) stock could be next leader2025 Trading Volume Trends & Safe Entry Zone Identification - newser.com
How Cue Biopharma Inc. stock performs in rate cut cycles2025 Geopolitical Influence & Advanced Swing Trade Entry Plans - newser.com
Can Cue Biopharma Inc. (1UC) stock expand revenue streams2025 Market Overview & Smart Investment Allocation Insights - newser.com
What dividend safety score for Cue Biopharma Inc. stockJuly 2025 Analyst Calls & Community Verified Watchlist Alerts - newser.com
Is Cue Biopharma Inc. stock gaining market shareWeekly Stock Analysis & Free Safe Capital Growth Stock Tips - newser.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Is Cue Biopharma Inc. stock attractive for hedge fundsBond Market & Fast Entry Momentum Trade Alerts - newser.com
Trend analysis for Cue Biopharma Inc. this week2025 Market WrapUp & Safe Capital Allocation Plans - newser.com
Cue Biopharma Inc Azioni (CUE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):